7000 drugs to delist from NHI reimbursement schedule

The drugs of no completing the efficacy equivalent tests until the end of April seem to be ousted from the NHI reimbursement schedule as planned, the MOHW said on March 7.

The MOHW also said that the above plan would never be postponed again but finalized in April for an official announcement, indicating that about over 7 thousand products would be delisted from the NHI reimbursement schedu...